Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default
David B. Yaden, Dylan Earp, Marianna Graziosi, Dara Friedman-Wheeler, Jason B. Luoma, Matthew W. Johnson
Frontiers in Psychology May 23, 2022 DOI: 10.3389/fpsyg.2022.873279 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | LSD Psilocybin Psychedelic-assisted therapy |
| Keywords | Psychedelics Psychedelic assisted therapy Psychedelic treatment Psychedelic integration Psychedelic preparation Psychotherapeutic modalities Cbt Dbt Behavioral therapy Psychological frameworks Psychotherapy Evidence-based treatment Optimal outcomes Therapeutic impact Gold standard Effective therapy Best practices Empirical backing Safety Practical application |
| Citations | 106 |
| Key points | Argues that cognitive-behavioral therapies, especially ACT, have the strongest rationale for psychedelic-assisted psychotherapy due to cultural sensitivity, minimal speculative assumptions, and strong empirical support. |
Abstract
The acute subjective effects of psychedelics are responsive to users’ expectations and surroundings (i.e., “set and setting”). Accordingly, a great deal of thought has gone into designing the psychosocial context of psychedelic administration in clinical settings. But what theoretical paradigms inform these considerations about set and setting? Here, we describe several historical, sociological influences on current psychedelic administration in mainstream European and American clinical research settings, including: indigenous practices, new age spirituality from the 1960s, psychodynamic/psychoanalytic approaches, and cognitive-behavioral approaches. We consider each of these paradigms and determine that cognitive-behavioral therapies, including newer branches such as acceptance and commitment therapy (ACT), have the strongest rationale for psychedelic-assisted psychotherapy going forward. Our primary reasons for advocating for cognitive-behavioral approaches include, (1) they avoid issues of cultural insensitivity, (2) they make minimal speculative assumptions about the nature of the mind and reality, (3) they have the largest base of empirical support for their safety and effectiveness outside of psychedelic therapy. We then propose several concepts from cognitive-behavioral therapies such as CBT, DBT, and ACT that can usefully inform the preparation, session, and integration phases of psychedelic psychotherapy. Overall, while there are many sources from which psychedelic psychotherapy could draw, we argue that current gold-standard, evidence-based psychotherapeutic paradigms provide the best starting point in terms of safety and efficacy.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
Argues that cognitive-behavioral approaches, especially acceptance and commitment therapy, have the strongest rationale for informing psychedelic-assisted psychotherapy.
Synthesized
Comparable studies
Other theoretical and historical papers on LSD and psychedelic-assisted therapy, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Flashback: psychiatric experimentation with LSD in historical perspective. | 2005 | Historical analysis | |
| LSD therapy in Dutch psychiatry: changing socio-political settings and medical sets. | 2002 | Theoretical or philosophical paper | |
| Psychedelics and psychotherapy in Canada: Humphry Osmond and Aldous Huxley. | 2018 | Historical analysis | |
| Psychedelic crossings: American mental health and LSD in the 1970s. | 2019 | Historical analysis | |
| Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded. | 2023 | Theoretical or philosophical paper |
Citations in the library
Cited by 88
- Psychedelics promote plasticity by directly binding to BDNF receptor TrkB Nature Neuroscience June 1, 2023
- Pharmacological, neural, and psychological mechanisms underlying psychedelics: a critical review Neuroscience & Biobehavioral Reviews September 1, 2022
- Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies. JAMA Psychiatry July 1, 2023
- Therapeutic mechanisms of psychedelics and entactogens. Neuropsychopharmacology July 24, 2023
- The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder PLoS One March 14, 2024
and 83 more in the library
Cites 38
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Frontiers in Human Neuroscience 2014
and 33 more in the library